Overview

Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

Status:
Recruiting
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
The overall objectives of the study are to evaluate long-term safety of CTP-543 and to assess long-term effects of CTP-543 on treating hair loss in adult patients with chronic, moderate to severe alopecia areata.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Concert Pharmaceuticals